Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (421-430 of 3,134) with videos related to

Pageof 314
Sort By:
Cytotherapy|October 6, 2007
Adipose-derived stem cells and chondrogenesisY Wei, X Sun, W Wang, et al.
Cytotherapy|February 25, 2009
Hematopoietic engraftment of XLA bone marrow CD34(+) cells in NOG/SCID miceThomas Moreau, Florence Bardin, Vincent Barlogis, et al.
Cytotherapy|February 26, 2009
SEMG-1 expression in early stage chronic lymphocytic leukemiaSharif Uddin Ahmed, Farouk Meklat, Masum Shahriar, et al.
Cytotherapy|February 26, 2009
Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of actionKeiichi Mitsuyama, Michio Sata
Cytotherapy|April 1, 2009
Similar proteomic profiles of human mesenchymal stromal cells from different donorsCarolina Lazzarotto-Silva, Renata Binato, Bárbara Du Rocher, et al.
Cytotherapy|April 1, 2009
Injectable soft-tissue augmentation by tissue engineering and regenerative medicine with human mesenchymal stromal cells, platelet-rich plasma and hyaluronic acid scaffoldsKazuto Okabe, Yoichi Yamada, Kenji Ito, et al.
Cytotherapy|April 2, 2009
Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosisD Uckan, E Kilic, P Sharafi, et al.
Cytotherapy|January 20, 2009
Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expressionJ J Montesinos, E Flores-Figueroa, S Castillo-Medina, et al.
Cytotherapy|October 7, 2008
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trialS Arai, R Meagher, M Swearingen, et al.
Cytotherapy|April 7, 2009
Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?Jeffrey S Miller
Pageof 314

Showing results (421-430 of 3,134) with videos related to

Sort By:
Pageof 314
Cytotherapy|October 6, 2007
Adipose-derived stem cells and chondrogenesisY Wei, X Sun, W Wang, et al.
Cytotherapy|February 25, 2009
Hematopoietic engraftment of XLA bone marrow CD34(+) cells in NOG/SCID miceThomas Moreau, Florence Bardin, Vincent Barlogis, et al.
Cytotherapy|February 26, 2009
SEMG-1 expression in early stage chronic lymphocytic leukemiaSharif Uddin Ahmed, Farouk Meklat, Masum Shahriar, et al.
Cytotherapy|February 26, 2009
Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of actionKeiichi Mitsuyama, Michio Sata
Cytotherapy|April 1, 2009
Similar proteomic profiles of human mesenchymal stromal cells from different donorsCarolina Lazzarotto-Silva, Renata Binato, Bárbara Du Rocher, et al.
Cytotherapy|April 1, 2009
Injectable soft-tissue augmentation by tissue engineering and regenerative medicine with human mesenchymal stromal cells, platelet-rich plasma and hyaluronic acid scaffoldsKazuto Okabe, Yoichi Yamada, Kenji Ito, et al.
Cytotherapy|April 2, 2009
Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosisD Uckan, E Kilic, P Sharafi, et al.
Cytotherapy|January 20, 2009
Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expressionJ J Montesinos, E Flores-Figueroa, S Castillo-Medina, et al.
Cytotherapy|October 7, 2008
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trialS Arai, R Meagher, M Swearingen, et al.
Cytotherapy|April 7, 2009
Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?Jeffrey S Miller
Pageof 314